[HTML][HTML] Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia
AM Dickinson, J Norden, S Li, I Hromadnikova… - Frontiers in …, 2017 - frontiersin.org
The success of hematopoietic stem cell transplantation (HSCT) lies with the ability of the
engrafting immune system to remove residual leukemia cells via a graft-versus-leukemia …
engrafting immune system to remove residual leukemia cells via a graft-versus-leukemia …
Peptides naturally presented by MHC class I molecules
HG Rammensee, K Falk… - Annual review of …, 1993 - annualreviews.org
MHC class I molecules are peptide receptors of stringent specificity which however still allow
millions of different ligands. This is achieved by the following specificity characteristics …
millions of different ligands. This is achieved by the following specificity characteristics …
[HTML][HTML] HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Background The human leucocyte antigen (HLA) complex controls adaptive immunity by
presenting defined fractions of the intracellular and extracellular protein content to immune …
presenting defined fractions of the intracellular and extracellular protein content to immune …
MHC molecules as peptide receptors
HG Rammensee, K Falk, O Rötzschke - Current opinion in immunology, 1993 - Elsevier
The central unit for regulation of the specific immune system is a trimolecular complex made
up of the T cell antigen receptor, the MHC molecule, and the MHC ligand. The third …
up of the T cell antigen receptor, the MHC molecule, and the MHC ligand. The third …
The HLA Ligand Atlas-A resource of natural HLA ligands presented on benign tissues
The human leukocyte antigen (HLA) complex regulates the adaptive immune response by
showcasing the intracellular and extracellular protein content to the immune system, where …
showcasing the intracellular and extracellular protein content to the immune system, where …
Hematopoietic stem cell transplantation and cellular therapy
HJ Kolb - Hla, 2017 - Wiley Online Library
Allogeneic stem cell transplantation is a form of immunotherapy that has increased the
chances of survival for patients with relapsed leukemia and high risk leukemia in remission …
chances of survival for patients with relapsed leukemia and high risk leukemia in remission …
PA28γ, the ring that makes tumors invisible to the immune system?
P Cascio - Biochimie, 2024 - Elsevier
ABSTRACT PA28γ is a proteasomal interactor whose main and most known function is to
stimulate the hydrolytic activity of the 20S proteasome independently of ubiquitin and ATP …
stimulate the hydrolytic activity of the 20S proteasome independently of ubiquitin and ATP …
The HLA Ligand Atlas. Defining Actionable Targets For T-Cell-Based Immunotherapy
A Marcu - 2022 - tobias-lib.ub.uni-tuebingen.de
Over the past two decades, immunotherapy has become the fourth pillar in cancer treatment
alongside surgery, radiotherapy, and chemotherapy. Immune checkpoint blockade shows …
alongside surgery, radiotherapy, and chemotherapy. Immune checkpoint blockade shows …
Клинико-иммунологическая характеристика течения урогенных реактивных артритов у европеоидного населения Западной Сибири/МА Королев
МА Королёв - 2008 - static.freereferats.ru
Актуальность темы: В течение последних десятилетий отмечается прогрессирующий
рост урогекитальных инфекций (УГИ)[Прилепская ВН и соавт., 2004; Шубин СВ., 2008; …
рост урогекитальных инфекций (УГИ)[Прилепская ВН и соавт., 2004; Шубин СВ., 2008; …
A Cellular Travelogue Major Highways, Secret Hideouts, Spa Cuisine
EE Sercarz - Progress in Immunology Vol. VIII, 1993 - Springer
Any account of progress in the area of antigen processing and presentation is necessarily a
story of the past few years. In 1987, when Bjorkman, Wiley and their colleagues solved the …
story of the past few years. In 1987, when Bjorkman, Wiley and their colleagues solved the …